Edinburgh Molecular Imaging is a startup based in the United Kingdom.
Based in the United Kingdom, Edinburgh Molecular Imaging is a startup.
Edinburgh Molecular Imaging (EM Imaging) is a clinical-stage biotechnology spin-out from the University of Edinburgh developing a C-Met molecular targeting technology platform. The company is developing a radiotherapeutic agent for cancer treatment alongside a fluorescent optical imaging agent.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.